174 related articles for article (PubMed ID: 38514481)
1. Radiomics-based nomogram guides adaptive de-intensification in locoregionally advanced nasopharyngeal carcinoma following induction chemotherapy.
Wang SX; Yang Y; Xie H; Yang X; Liu ZQ; Li HJ; Huang WJ; Luo WJ; Lei YM; Sun Y; Ma J; Chen YF; Liu LZ; Mao YP
Eur Radiol; 2024 Mar; ():. PubMed ID: 38514481
[TBL] [Abstract][Full Text] [Related]
2. Combining tumor response and personalized risk assessment: Potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
Luo WJ; Zou WQ; Liang SB; Chen L; Zhou GQ; Peng H; Li WF; Liu X; Sun Y; Lin AH; Ma J; Mao YP
Radiother Oncol; 2021 Feb; 155():56-64. PubMed ID: 33039423
[TBL] [Abstract][Full Text] [Related]
3. MRI-based radiomics to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A multicenter study.
Shen H; Yin J; Niu R; Lian Y; Huang Y; Tu C; Liu D; Wang X; Lan X; Yuan X; Zhang J
Radiother Oncol; 2022 Jun; 171():107-113. PubMed ID: 35461950
[TBL] [Abstract][Full Text] [Related]
4. MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma.
Pei W; Wang C; Liao H; Chen X; Wei Y; Huang X; Liang X; Bao H; Su D; Jin G
BMC Cancer; 2022 Jul; 22(1):739. PubMed ID: 35794590
[TBL] [Abstract][Full Text] [Related]
5. A dynamic nomogram combining tumor stage and magnetic resonance imaging features to predict the response to induction chemotherapy in locally advanced nasopharyngeal carcinoma.
Jiang Y; Liang Z; Chen K; Li Y; Yang J; Qu S; Li L; Zhu X
Eur Radiol; 2023 Mar; 33(3):2171-2184. PubMed ID: 36355201
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Wei Z; Zhang Z; Luo J; Li N; Peng X
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
[TBL] [Abstract][Full Text] [Related]
7. MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma.
Zhao L; Gong J; Xi Y; Xu M; Li C; Kang X; Yin Y; Qin W; Yin H; Shi M
Eur Radiol; 2020 Jan; 30(1):537-546. PubMed ID: 31372781
[TBL] [Abstract][Full Text] [Related]
8. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
[TBL] [Abstract][Full Text] [Related]
9. Nomogram to predict the benefit of additional induction chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Analysis of a multicenter, phase III randomized trial.
Zhang Y; Li WF; Liu X; Chen L; Sun R; Sun Y; Liu Q; Ma J
Radiother Oncol; 2018 Oct; 129(1):18-22. PubMed ID: 29258695
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of adjuvant chemotherapy/maintenance chemotherapy after induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Experiences of two centers.
Tao HY; He F; Shi QY; Liu R; Wang ZL; Du KP; Li JF; Liu H; Lu ZQ; Zhang JJ; Bai YH
Cancer Med; 2023 Mar; 12(6):6811-6824. PubMed ID: 36420689
[TBL] [Abstract][Full Text] [Related]
11. MRI-based radiomics nomogram for predicting temporal lobe injury after radiotherapy in nasopharyngeal carcinoma.
Hou J; Li H; Zeng B; Pang P; Ai Z; Li F; Lu Q; Yu X
Eur Radiol; 2022 Feb; 32(2):1106-1114. PubMed ID: 34467454
[TBL] [Abstract][Full Text] [Related]
12. CT-based radiomics signature analysis for evaluation of response to induction chemotherapy and progression-free survival in locally advanced hypopharyngeal carcinoma.
Liu X; Long M; Sun C; Yang Y; Lin P; Shen Z; Xia S; Shen W
Eur Radiol; 2022 Nov; 32(11):7755-7766. PubMed ID: 35608663
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Response to Induction Chemotherapy Plus Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma Based on MRI Radiomics and Delta Radiomics: A Two-Center Retrospective Study.
Xi Y; Ge X; Ji H; Wang L; Duan S; Chen H; Wang M; Hu H; Jiang F; Ding Z
Front Oncol; 2022; 12():824509. PubMed ID: 35530350
[TBL] [Abstract][Full Text] [Related]
14. Nomogram Predicting the Benefits of Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy After Induction Chemotherapy in Stages II-IVb Nasopharyngeal Carcinoma.
Liu SL; Sun XS; Lu ZJ; Chen QY; Lin HX; Tang LQ; Bei JX; Guo L; Mai HQ
Front Oncol; 2020; 10():539321. PubMed ID: 33240805
[TBL] [Abstract][Full Text] [Related]
15. A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinoma.
Sun MX; Zhao MJ; Zhao LH; Jiang HR; Duan YX; Li G
Radiat Oncol; 2023 Apr; 18(1):67. PubMed ID: 37041545
[TBL] [Abstract][Full Text] [Related]
16. MRI-based clinical radiomics nomogram may predict the early response after concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma.
Wu M; Xu W; Fei Y; Li Y; Yuan J; Qiu L; Zhang Y; Chen G; Cheng Y; Cao Y; Sun X; Zhou S
Front Oncol; 2023; 13():1192953. PubMed ID: 37256173
[TBL] [Abstract][Full Text] [Related]
17. Establishing and applying nomograms based on the 8th edition of the UICC/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy.
Xu C; Chen YP; Liu X; Li WF; Chen L; Mao YP; Zhang Y; Guo R; Zhou GQ; Tang LL; Lin AH; Sun Y; Ma J
Oral Oncol; 2017 Jun; 69():99-107. PubMed ID: 28559028
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a prognostic nomogram for patients with locoregionally advanced nasopharyngeal carcinoma incorporating clinical characteristics and dynamic changes in hematological and inflammatory markers.
Liu Q; Ma L; Ma H; Yang L; Xu Z
Front Oncol; 2022; 12():1032213. PubMed ID: 36387244
[TBL] [Abstract][Full Text] [Related]
19. Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Mu X; Liu H; Wu J; Chen S; Peng X; Wang J; Wei Z; He L; Liu J; Lu Z; Su Y
Aging (Albany NY); 2022 Aug; 14(16):6727-6739. PubMed ID: 36036759
[TBL] [Abstract][Full Text] [Related]
20. CT-Based Radiomics Nomogram for Prediction of Progression-Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma.
Yan C; Shen DS; Chen XB; Su DK; Liang ZG; Chen KH; Li L; Liang X; Liao H; Zhu XD
Cancer Manag Res; 2021; 13():6911-6923. PubMed ID: 34512030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
